1. TNFR2-expressing CD4+Foxp3+ regulatory T cells in cancer immunology and immunotherapy
   Jiang He et al, 2019, Cancer Immunotherapy CrossRef
2. Effects of miR-107 on the Chemo-drug sensitivity of breast cancer cells
   Yong Luo et al, 2019, Open Medicine CrossRef
3. TNFR2: A Novel Target for Cancer Immunotherapy
   Éva S. Vanamee et al, 2017, Trends in Molecular Medicine CrossRef
4. TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
   Yuqiao Sheng et al, 2018, Frontiers in Immunology CrossRef
5. The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
   Hiroyuki Takahashi et al, 2022, Cells CrossRef
6. Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
   Muchun Li et al, 2022, Frontiers in Oncology CrossRef
7. ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
   Samantha A Hutchinson et al, 2019, Nutrients CrossRef
8. TNFR2: Role in Cancer Immunology and Immunotherapy
   Yang Yang et al, 2021, ImmunoTargets and Therapy CrossRef
9. Mechanism of the enhancing effects of miR‑93 on resistance of breast cancer MCF‑7 cells to adriamycin
   Qian Wang et al, 2018, Oncology Letters CrossRef
10. Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
    Juliane Medler et al, 2022, Cancers CrossRef
11. Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells
    Ana Flávia Teixeira Rossi et al, 2022, World Journal of Gastroenterology CrossRef
12. Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
    Adit Ben-Baruch, 2022, Frontiers in Immunology CrossRef
13. Unraveling the Cellular Mechanism of Assembling Cholesterols for Selective Cancer Cell Death
    Huaimin Wang et al, 2019, Molecular Cancer Research CrossRef
14. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer
    Mahmoud T. Abo-Elfadl et al, 2020, Cytokine CrossRef
15. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
    Tamir Baram et al, 2021, Frontiers in Oncology CrossRef
16. Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma
    Dong Yang et al, 2018, Oncology Letters CrossRef
17. Expression of tumor necrosis factor receptor 2 in human non‐small cell lung cancer and its role as a potential prognostic biomarker
    Yan Wen Zhang et al, 2019, Thoracic Cancer CrossRef
18. A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
    Mohammad A. I. Al-Hatamleh et al, 2019, Journal of Oncology CrossRef
19. The distinct role of CD73 in the progression of pancreatic cancer
    Liangjing Zhou et al, 2019, Journal of Molecular Medicine CrossRef
20. The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
    Nurul Hakimah Mohd Salim et al, 2023, Biomedicines CrossRef